|
|||||
|
|
Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease |
|
| Authors: | M. L. Barclay L. K. Stamp |
| Affiliation: | 1. Department of Medicine, University of Otago, Christchurch, New 2. Zealand;3. Clinical Pharmacology, Christchurch Hospital, Christchurch, New |
| Abstract: | |
| Keywords: | |